← All Senti Biosciences, INC filings

Senti Biosciences, INC Form 4 insider transactions

NASDAQ
SNTI
Senti Biosciences, INC
Form 4: Senti Biosciences Director James J. Collins Acquires Stock Options
Director James J. Collins reports acquisition of stock options in Senti Biosciences.
NASDAQ
SNTI
Senti Biosciences, INC
Form 4: Senti Biosciences Director Brenda Cooperstone Acquires Stock Options
Director Brenda Cooperstone acquired 62,500 stock options in Senti Biosciences on July 10, 2024.